top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjcvp

Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events Introduction Cardiovascular disease (CVD) is widespread, ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Laura A. Fortuna, Pamala A. Pawloski, Emily D. Parker, Nicole K. Trower, Thomas E. Kottke

Date : 01/01/2016 Item size : 263457 bytes
Ehjcvp

In this issue of the journal, Serebruany and co-workers report data from a study of clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment following percutaneous ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2016 Item size : 96542 bytes
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients Patients on digitalis were more ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Julia W. Erath, Mate Vamos, Stefan H. Hohnloser

Date : 01/07/2016 Item size : 225615 bytes
Ehjcvp

The decreased risk of AF remained significant after adjusting for age, sex, and comorbidities with a hazard ratio (95% CI) of 0.76 (0.571.00), P0.047 associated with TZD treatment compared with other ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Laila Staerk, Jonas Bjerring Olesen, Christian Torp-Pedersen, Morten Lock ...

Date : 08/11/2016 Item size : 223886 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

In recent years, guidance from both the US Food and Drug Administration (FDA)2 and the European Medicines Agency (EMA)3 addressing evaluation of the cardiovascular risk of new antidiabetic drugs for ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, J. Rick Turner, Dilip R. Karnad, Snehal Kothari, Alan Metz, Hitesh Patel, Erica Caveney

Date : 01/01/2017 Item size : 128050 bytes
Ehjcvp

Abstract The 2016 European Society of Cardiology Heart Failure society as well as the 2016 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Bertram Pitt, João Pedro Ferreira, Faiez Zannad

Date : 01/01/2017 Item size : 378836 bytes
Ehjcvp

Abstract The 2016 European Society of Cardiology Heart Failure society as well as the 2016 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Bertram Pitt, João Pedro Ferreira, Faiez Zannad

Date : 01/08/2016
Ehjcvp

The 2016 European Society of Cardiology Heart Failure society as well as the 2016 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure (HF) ...

European Heart Journal - Cardiovascular Pharmacotherapy, Pitt, Bertram, Pedro Ferreira, João, Zannad, Faiez

Date : 01/01/2017 Item size : 374614 bytes